Investors / Germany / TVM Capital Life Science
TVM Capital Life Science
Venture capital · Munich, Germany · Europe
TVM Capital Life Science is a venture capital firm focused exclusively on life sciences since 2012, having originated from Techno Venture Management, launched in 1983. It invests through a dual strategy: forming single-asset project-focused companies around early-stage therapeutics with strategic partner Eli Lilly, and investing in commercial-stage medtech, diagnostics, digital health and late-stage therapeutics.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiopharmamedtechdiagnosticsdigital healththerapeutics
Your fit with TVM Capital Life Science
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsTVM Capital Life Science lists 10 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 38% of its companies are based in United States. It invests most often alongside Aspire Ventures, BayBG Venture Capital and Green Park & Golf Ventures.
No funding round on record names TVM Capital Life Science yet, so the figures come from its portfolio page.
Round figures show recent activity, not TVM Capital Life Science's whole history. Rounds on record name 0 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 69th | 4 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare TVM Capital Life Science head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its sitePortfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Access Vascular offers a suite of vascular access devices that use a novel, patented biomaterial featuring MIMIX technology | Healthcare & Biotech | Portfolio page | ||
| AL-S Pharma is advancing AP-101, a first-in-class Phase 3-ready antibody that selectively targets toxic, misfolded SOD1 in both sporadic ALS and SOD1-ALS. | Healthcare & Biotech | Portfolio page | ||
| Egg Medical produces whole-room scatter radiation protection products for interventional labs. | Healthcare & Biotech | Portfolio page | ||
| Emovi develops and provides a medical device called KneeKG that measures the 3D dynamic alignment of the knee | Healthcare & Biotech | Portfolio page | ||
| Jacobian GmbH provides radiology solutions, including an AI platform for enterprise imaging | Healthcare & Biotech | Portfolio page | ||
| Kent Imaging Inc develops and provides medical imaging devices for wound care and tissue assessment | Healthcare & Biotech | Portfolio page | ||
| Leon Nanodrugs Life Science manufactures nanoparticle production systems | Healthcare & Biotech | Portfolio page | ||
| Myo digitalizes communication in elderly care, allowing care facilities, families, and service providers to communicate simply, quickly, and digitally with each other. | Healthcare & Biotech | Portfolio page | ||
| The company designs and manufactures state-of-the-art products for dental restorations, cranio-maxillofacial surgeries, and the treatment of sleep-breathing disorders | Healthcare & Biotech | Portfolio page | ||
| Vektor Medical develops an arrhythmia analysis tool to improve cardiac ablation outcomes and optimize workflows | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- tvm-capital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get TVM Capital Life Science's profile as data
Pull TVM Capital Life Science's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/tvm-capital.com
# also
GET /v1/firms/tvm-capital.com/portfolio
GET /v1/firms/tvm-capital.com/coinvestors
GET /v1/firms/tvm-capital.com/news